Preclinical studies with JAA-F11 anti-Thomsen-Friedenreich monoclonal antibody for human breast cancer

Cancer statistics, 2011

(2011) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Bevacizumab for the first-line treatment of human epidermal growth factor receptor 2-negative advanced breast cancer

(2011) Margarida Damasceno   CURRENT OPINION IN ONCOLOGY

In vivo tumor cell adhesion in the pulmonary microvasculature is exclusively mediated by tumor cell - endothelial cell interaction

(2010) Peter Gassmann et al.   BMC CANCER

Management of triple negative breast cancer

(2010) Catherine Oakman et al.   BREAST

Novel Interaction of MUC4 and Galectin: Potential Pathobiological Implications for Metastasis in Lethal Pancreatic Cancer

(2010) S. Senapati et al.   CLINICAL CANCER RESEARCH

Antineoplastic effects of an Aurora B kinase inhibitor in breast cancer

(2010) Christopher P Gully et al.   Molecular Cancer

Comment Re: MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?

(2009) A. Hollestelle et al.   CANCER RESEARCH

MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?

(2009) Ann F. Chambers   CANCER RESEARCH

Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery

(2009) Jessica Kao et al.   PLoS One

Tumor immunolocalization using 124I-iodine-labeled JAA-F11 antibody to Thomsen–Friedenreich alpha-linked antigen

(2007) Richa Chaturvedi et al.   APPLIED RADIATION AND ISOTOPES